PROCEPT BioRobotics (PRCT) CLO sells 304 shares to cover RSU taxes

Rhea-AI Filing Summary

PROCEPT BioRobotics Corp executive reports small share sale tied to tax withholding. EVP, Chief Legal Officer and Corporate Secretary Alaleh Nouri sold 304 shares of common stock at an average price of $28.1532 per share. According to the footnote, the sale was made solely to cover tax withholding obligations from the vesting of restricted stock units, rather than as a discretionary open-market transaction. After this sale, Nouri directly holds 110,717 shares of PROCEPT BioRobotics common stock, indicating the transaction is minor relative to her overall stake.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Nouri Alaleh

(Last) (First) (Middle)

C/O PROCEPT BIOROBOTICS CORPORATION

150 BAYTECH DRIVE

(Street)

SAN JOSE CALIFORNIA 95134

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PROCEPT BioRobotics Corp [ PRCT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, CLO, CORP. SEC.

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/17/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/17/2026		S		304(1)	D	$28.1532	110,717	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units.

Remarks:

	/s/ Jonathan Stone, Attorney-in-Fact for Alaleh Nouri	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did PROCEPT BioRobotics (PRCT) insider Alaleh Nouri report in this Form 4?

Alaleh Nouri reported selling 304 shares of PROCEPT BioRobotics common stock at $28.1532 per share. The filing states the sale was executed to cover tax withholding obligations related to vesting restricted stock units, not as a discretionary open-market trade.

Why did PROCEPT BioRobotics (PRCT) executive Alaleh Nouri sell 304 shares?

The shares were sold specifically to cover tax withholding obligations from the vesting of restricted stock units. The footnote explains this purpose, indicating the transaction is a routine, compensation-related event rather than a discretionary decision to reduce her investment in PRCT.

How many PROCEPT BioRobotics (PRCT) shares does Alaleh Nouri hold after this transaction?

After the sale of 304 shares, Alaleh Nouri directly holds 110,717 shares of PROCEPT BioRobotics common stock. This shows the transaction affected only a small portion of her overall holdings, suggesting it was a limited, administrative adjustment for tax purposes.

Was the PROCEPT BioRobotics (PRCT) insider sale an open-market trade?

While coded as a sale, the filing’s footnote clarifies the transaction was executed to satisfy tax withholding linked to restricted stock unit vesting. This distinguishes it from a typical discretionary open-market sale aimed at changing the insider’s investment exposure.

What role does PROCEPT BioRobotics (PRCT) insider Alaleh Nouri hold?

Alaleh Nouri serves as Executive Vice President, Chief Legal Officer and Corporate Secretary at PROCEPT BioRobotics. Her Form 4 filing reflects equity compensation activity and related tax withholding, providing transparency on how her stock-based awards are administered.